European journal of obstetrics, gynecology, and reproductive biology · 2025
Parturients with diabetes and associated outcomes with Macrosomic newborns.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zullo Fabrizio, Logue Teresa C, Di Mascio Daniele, Rizzo Giuseppe, Giancotti Antonella, Hoffman Matthew K, Sorrenti Sara, Mendez Figueroa Hector, Sciscione Anthony C, Fishel Bartal Michal, Chauhan Suneet P
Аннотация
BACKGROUND: Adverse neonatal and maternal outcomes are understudied for parturients with diabetes who deliver macrosomic newborns.
OBJECTIVE: We hypothesized that composite-neonatal (CNAO) and maternal adverse outcomes (CMAO) would be significantly higher for individuals with diabetes macrosomic newborns.
STUDY DESIGN: This was a secondary analysis of APEX cohorts. The inclusion criteria were parturients with diabetes that were at least 34.0 weeks. CNAO included: Apgar score < 7 at 5 min, neonatal fracture, intracranial hemorrhage, neonatal brachial plexus palsy (NBPP), treated hypotension, or hypoxic encelopathy. CMAO included: chorioamnionitis, EBL ≥ 1,000 mL or 3rd/4th degree lacerations. Multivariate Poisson regression with robust error variance was used to calculate incidence-rate-ratios (IRR), and adjusted IRR (aIRR) RESULTS: Among the 118,422 cohorts in APEX study, 8,410(7.5 %) had diabetes. The inclusion criteria were met by 584 (6.9 %) diabetic parturients, and among them 491 (84.0 %) delivered category I macrosomia, and 93 (16.0 %) with category II/III. The overall CNAO was 7.2 %, and it was significantly higher for parturients who delivered newborns with BW ≥ 4,500 g (15.0%) versus 4,000-4,499 g (5.7%; aIRR2.64; 95 %-CI 1.39-5.01; p: 0.006). The overall CMAO was 29.9 % and it was similar when BW ≥ 4,500 g (32.2 %) versus when BW was 4,000-4,499 (29.5 %; aIRR 1.05; 0.71-1.57). The overall rate of shoulder dystocia (SD) among macrosomic newborns was 14.7 % and it was significantly higher among those with birthweight ≥ 4,500g (28.0%) versus those with 4,000-4,449 g (12.2 %; aIRR2.21; 95 %CI 1.39-3.53). The rate of cesarean delivery did not differ between the two groups(aIRR 1.24;95 % CI 0.89-1.72).
CONCLUSIONS: Among parturients with diabetes, who delivered newborns with birthweight ≥ 4,500 g versus 4,000-4,499 g, CNAO and SD were twofold higher. Thus, there is an imperative to identify newborns among individuals with diabetes whose newborn will be 4,000-4,499 versus ≥ 4,500 g.
OBJECTIVE: We hypothesized that composite-neonatal (CNAO) and maternal adverse outcomes (CMAO) would be significantly higher for individuals with diabetes macrosomic newborns.
STUDY DESIGN: This was a secondary analysis of APEX cohorts. The inclusion criteria were parturients with diabetes that were at least 34.0 weeks. CNAO included: Apgar score < 7 at 5 min, neonatal fracture, intracranial hemorrhage, neonatal brachial plexus palsy (NBPP), treated hypotension, or hypoxic encelopathy. CMAO included: chorioamnionitis, EBL ≥ 1,000 mL or 3rd/4th degree lacerations. Multivariate Poisson regression with robust error variance was used to calculate incidence-rate-ratios (IRR), and adjusted IRR (aIRR) RESULTS: Among the 118,422 cohorts in APEX study, 8,410(7.5 %) had diabetes. The inclusion criteria were met by 584 (6.9 %) diabetic parturients, and among them 491 (84.0 %) delivered category I macrosomia, and 93 (16.0 %) with category II/III. The overall CNAO was 7.2 %, and it was significantly higher for parturients who delivered newborns with BW ≥ 4,500 g (15.0%) versus 4,000-4,499 g (5.7%; aIRR2.64; 95 %-CI 1.39-5.01; p: 0.006). The overall CMAO was 29.9 % and it was similar when BW ≥ 4,500 g (32.2 %) versus when BW was 4,000-4,499 (29.5 %; aIRR 1.05; 0.71-1.57). The overall rate of shoulder dystocia (SD) among macrosomic newborns was 14.7 % and it was significantly higher among those with birthweight ≥ 4,500g (28.0%) versus those with 4,000-4,449 g (12.2 %; aIRR2.21; 95 %CI 1.39-3.53). The rate of cesarean delivery did not differ between the two groups(aIRR 1.24;95 % CI 0.89-1.72).
CONCLUSIONS: Among parturients with diabetes, who delivered newborns with birthweight ≥ 4,500 g versus 4,000-4,499 g, CNAO and SD were twofold higher. Thus, there is an imperative to identify newborns among individuals with diabetes whose newborn will be 4,000-4,499 versus ≥ 4,500 g.